Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Adopts AMA Coding Recommendations For Cancer Drug Administration

This article was originally published in The Pink Sheet Daily

Executive Summary

New codes will allow reimbursement for each infusion of chemotherapy and non-chemo drugs as well as for preparation of pharmaceuticals and management of adverse events. CMS is awaiting a GAO report on average sales price-based reimbursement.

You may also be interested in...



CMS To Increase Flu Vaccine Administration Fees In Final Part B Rule

The Center for Medicare & Medicaid Services' final 2005 Physician Fee Schedule is understood to include a payment increase for administration of the flu vaccine to Medicare beneficiaries

CMS To Increase Flu Vaccine Administration Fees In Final Part B Rule

The Center for Medicare & Medicaid Services' final 2005 Physician Fee Schedule is understood to include a payment increase for administration of the flu vaccine to Medicare beneficiaries

Medicare Part B Average Sales Prices Will Be Published In December – CMS

2005 payment rates, which will be based on third quarter 2004 data supplied by manufacturers, will not be ready in time to be included in CMS's final Physician Fee Schedule rule, which the agency plans to release Nov. 1. The final rule will also include recommended billing code changes.

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel